Given the known role of β-catenin in promoting a non-T cell-inflamed TIME7, we examined whether LNP-CTNNB1 sufficiently reprogrammed the adaptive immune response in advanced-stage HCC. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.